We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Monitoring System Protects Nerves During Surgery

By HospiMedica International staff writers
Posted on 16 Jul 2012
A novel system allows intraoperative nerve monitoring during minimally invasive, robotic surgery for prostate cancer.

The ProPep Nerve Monitoring System is specifically designed for use during robotic-assisted radical prostatectomy (RP), the most common treatment for prostate cancer. More...
Fast, accurate and easy to use, the system gives the surgeon real-time feedback regarding the location and integrity of otherwise invisible nerves during RP. The ProPep Nerve Monitoring System consists of the Pep Monitor, which generates the specific electrical signal used to stimulate the tissue of interest, and records, analyzes, and displays the tissues response to that signal.

The Pep Control Switch enables the surgeon to switch the robotic bipolar instrument from bipolar/cautery mode to Pep stimulation mode and back again, since the electrical stimulation signal generated by the Pep Monitor is delivered through the surgeon’s robotic bipolar surgical instrument, eliminating the need to introduce a separate stimulation probe into the surgical field. Using the PrPep in simulation mode enables the surgeon to distinguish between nerve containing versus non-nerve-containing tissue.

The Pep Electrode Kit is a single use, disposable kit that contains the Pep Electrode and the Pep Electrode Introducer. The Pep Electrode is connected to the Pep Monitor and introduced into the surgical field via the Pep Electrode Introducer. The electrodes are placed into the levator ani muscle proximal to the urethral sphincter on either side of the prostate and a ground electrode is placed into the external abdominal wall. The ProPep Nerve Monitoring System is a product of ProPep Surgical (Austin, TX, USA), and has been approved by the US Food and Drug Administration (FDA).

“One of the biggest fears about prostate cancer surgery is the potential for nerve damage. To reduce the side effects associated with this nerve damage, the surgeon must do two things; spare the nerve tissue, and not damage the nerve tissue while sparing it,” said Randy Fagin, MD, chief medical advisor of ProPep.

“Currently, surgeons rely on anatomic landmarks to identify nerves during surgery but research has shown these landmarks are not always reliable, even if you successfully spare the nerve tissue.”

Related Links:

ProPep Surgical



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.